SCHEMBL9734941

SCHEMBL9734941

CCCCSCC(C)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.46
GMNN O75496 1/20 0.44
TP53 P04637 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
CYP2C9 P11712 1/20 0.44
BLM P54132 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CES1 P23141 1/20 0.41
CES2 O00748 1/20 0.39
TSHR P16473 1/20 0.38
NOS2 P35228 1/20 0.38
CA2 P00918 1/20 0.38
MAPK1 P28482 1/20 0.38
APEX1 P27695 1/20 0.37
GPR84 Q9NQS5 3/20 0.36
FFAR1 O14842 1/20 0.36
CA1 P00915 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7167169 0.94 MAPT (0.52) ACE2GMNNTP53POLBMAPT
SCHEMBL9355083 0.92 MAPT (0.55) ACE2GMNNTP53POLBMAPT
SCHEMBL9851243 0.92 MAPT (0.55) ACE2GMNNTP53POLBMAPT
SCHEMBL9106808 0.92 MAPT (0.55) ACE2GMNNTP53POLBMAPT
SCHEMBL11089311 0.92 MAPT (0.55) ACE2GMNNTP53POLBMAPT
SCHEMBL10639673 0.92 MAPT (0.55) ACE2GMNNTP53POLBMAPT
SCHEMBL8859536 0.87 ACE2 (0.43) ACE2GMNNTP53POLBMAPT
SCHEMBL9735363 0.87 ACE2 (0.39) ACE2NOS2APEX1
SCHEMBL17530133 0.84 GABRR1 (0.42) TP53BLMNOS2APEX1
SCHEMBL12134769 0.83 CES2 (0.44) ACE2GMNNTP53POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815478-B2 Colored curable composition, resist liquid, ink for inkjet printing, color filter, method of producing color filter, solid-state image sensor, liquid crystal display, organic EL display, image display device and colorant compound FUJIFILM CORPORATION (JP) 2014-08-26 US disclosed
US-20120264039-A1 COLORED CURABLE COMPOSITION, RESIST LIQUID, INK FOR INKJET PRINTING, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR, LIQUID CRYSTAL DISPLAY, ORGANIC EL DISPLAY, IMAGE DISPLAY DEVICE AND COLORANT COMPOUND FUJIFILM CORPORATION (JP) 2012-10-18 US disclosed
US-20110287244-A1 HYDROPHILIC FILM FUJIFILM CORPORATION (JP) 2011-11-24 US disclosed
US-20110076618-A1 LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PLATE MAKING METHOD THEREOF FUJIFILM CORPORATION (JP) 2011-03-31 US disclosed
US-5098599-A Aromatic esters with sulfide groups as liquid crystals MITSUBISHI RAYON COMPANY LTD. (JP) 1992-03-24 US disclosed
EP-0405983-A2 Optically active substance and liquid crystal composition MITSUBISHI RAYON CO., LTD (JP) 1991-01-02 EP disclosed
EP-0354355-A1 Optically active compound and liquid crystal composition MITSUBISHI RAYON CO., LTD. (JP) 1990-02-14 EP disclosed
EP-0185606-A2 Polymerizable thioester synergists THE GOODYEAR TIRE & RUBBER COMPANY (US) 1986-06-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264039-A1 COLORED CURABLE COMPOSITION, RESIST LIQUID, INK FOR INKJET PRINTING, COLOR FILTER, METHOD OF PRODUCING COLOR FILTER, SOLID-STATE IMAGE SENSOR, LIQUID CRYSTAL DISPLAY, ORGANIC EL DISPLAY, IMAGE DISPLAY DEVICE AND COLORANT COMPOUND CDYL, RET, NLRP1 ACE2 3333/4885GMNN 2678/4885TP53 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.